Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Immunogenicity of a Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 11 Years in Malaysia

NCT01254422 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT01254422
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01254422 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Immunogenicity of a Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 11 Years in Malaysia
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
December 2, 2010
Completion date
January 31, 2013
Enrollment
250 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

dengue fever, dengue hemorrhagic fever